Barcelona, Spain

Richard Spurring Roberts


 

Average Co-Inventor Count = 7.1

ph-index = 1


Company Filing History:


Years Active: 2015-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Richard Spurring Roberts: Innovator in Pharmaceutical Compounds

Introduction

Richard Spurring Roberts is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceutical compounds, holding a total of four patents. His work focuses on innovative solutions for treating lysosomal storage diseases and other related disorders.

Latest Patents

Among his latest patents, Richard has developed heteroaryl compounds and their uses. The application is directed to compounds of a specific formula and their salts and solvates. These compounds are designed for the treatment and prevention of lysosomal storage diseases, such as Gaucher's disease, as well as other disorders that are classified as synucleinopathies. His research includes methods for the preparation of these compounds and pharmaceutical compositions that incorporate them.

Career Highlights

Richard has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Minoryx Therapeutics S.L. and Syngenta Participations AG. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Richard has collaborated with esteemed colleagues, including Ana Maria García Collazo and Xavier Barril Alonso. These partnerships have further enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Richard Spurring Roberts is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the treatment of various diseases significantly. His innovative contributions continue to advance the field and offer hope for patients suffering from lysosomal storage diseases and synucleinopathies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…